Vitamin D levels and markers of arterial dysfunction in HIV

AIDS Research and Human Retroviruses

Volumn 28, Issue 8, 2012, Pages 793-797

  Shikuma, Cecilia M ^a   Seto, Todd ^a,b   Liang, Chin Yuan ^a   Bennett, Kara ^c   Degruttola, Victor ^c   Gerschenson, Mariana ^a   Stein, James H ^d   Budoff, Matthew ^e   Hodis, Howard N ^f   Delaney, Joseph A C ^g   Ogata Arakaki, Debra ^a   Pramyothin, Pornpoj ^h   Chow, Dominic ^a  

^a UNIVERSITY OF HAWAII   (United States)

^b QUEEN S MEDICAL CENTER   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

^h BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BRACHIAL ARTERY; CHEMOLUMINESCENCE; COMMON CAROTID ARTERY; CORRELATION COEFFICIENT; FEMALE; FRAMINGHAM RISK SCORE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOASSAY; KRUSKAL WALLIS TEST; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VASODILATATION;

ANTI-RETROVIRAL AGENTS; ARTERIES; BIOLOGICAL MARKERS; COHORT STUDIES; HAWAII; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RISK FACTORS; VASCULAR DISEASES; VITAMIN D;

EID: 84864249773     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2011.0086     Document Type: Article

References (29)

1. Reddy Vanga S, Good M, Howard PA, and Vacek JL: Role of vitamin D in cardiovascular health. Am J Cardiol 2010; 106:798-805.
2. Rodriguez M, Daniels B, Gunawardene S, and Robbins GK: High frequency of vitamin D deficiency in ambulatory HIV-positive patients. AIDS Res Hum Retroviruses 2009;25: 9-14.
3. Van Den Bout-Van Den Beukel CJ, Fievez L, Michels M, et al.: Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: Effects of antiretroviral therapy. AIDS Res Hum Retroviruses 2008;24:1375-1382.
4. Triant VA, Lee H, Hadigan C, and Grinspoon SK: Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 2007;92:2506-2512.
5. Stein JH, Klein MA, Bellehumeur JL, et al.: Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation 2001;104:257-262.
6. Stein JH, Merwood MA, Bellehumeur JL, et al.: Effects of pravastatin on lipoproteins and endothelial function in patients receiving human immunodeficiency virus protease inhibitors. Am Heart J 2004;147:E18.
7. Torriani FJ, Komarow L, Parker RA, et al.: Endothelial function in human immunodeficiency virus-infected antiretroviral- naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s. J Am Coll Cardiol 2008;52:569-576.
8. Selzer RH, Hodis HN, Kwong-Fu H, et al.: Evaluation of computerized edge tracking for quantifying intima-media thickness of the common carotid artery from B-mode ultrasound images. Atherosclerosis 1994;111:1-11.
9. Selzer RH, Mack WJ, Lee PL, Kwong-Fu H, and Hodis HN: Improved common carotid elasticity and intima-media thickness measurements from computer analysis of sequential ultrasound frames. Atherosclerosis 2001;154: 185-193.
10. Hodis HN, Mack WJ, LaBree L, et al.: The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998;128:262-269.
11. Hodis HN, Mack WJ, Lobo RA, et al.: Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001;135:939-953.
12. Carr JJ, Nelson JC, Wong ND, et al.: Calcified coronary artery plaque measurement with cardiac CT in population-based studies: Standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. Radiology 2005; 234:35-43.
13. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, and Detrano R: Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-832.
14. Zou G: A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004;159: 702-706.
15. Ginde AA, Liu MC, and Camargo CA Jr: Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009;169: 626-632.
16. De Boer IH, Kestenbaum B, Shoben AB, Michos ED, Sarnak MJ, and Siscovick DS: 25-Hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol 2009;20:1805-1812.
17. Targher G, Bertolini L, Padovani R, et al.: Serum 25-Hydroxyvitamin D3 concentrations and carotid artery intimamedia thickness among type 2 diabetic patients. Clin Endocrinol (Oxf) 2006;65:593-597.
18. Tarcin O, Yavuz DG, Ozben B, et al.: Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab 2009;94: 4023-4030.
19. Martins D, Wolf M, Pan D, et al.: Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: Data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2007; 167:1159-1165.
20. Melamed ML, Muntner P, Michos ED, et al.: Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: Results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol 2008;28:1179-1185.
21. Pilz S, Marz W, Wellnitz B, et al.: Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 2008;93:3927-3935.
22. Dobnig H, Pilz S, Scharnagl H, et al.: Independent association of low serum 25-hydroxyvitamin D and 1,25- dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008;168:1340-1349.
23. Kendrick J, Targher G, Smits G, and Chonchol M: 25- Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis 2009; 205:255-260.
24. Wang TJ, Pencina MJ, Booth SL, et al.: Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117: 503-511.
25. Pittas AG, Chung M, Trikalinos T, et al.: Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med 2010;152:307-314
26. Mehta S, Giovannucci E, Mugusi FM, et al.: Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality. PLoS ONE 2010;5:e8770.
27. Timms PM, Mannan N, Hitman GA, et al.: Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: Mechanisms for inflammatory damage in chronic disorders? QJM 2002;95:787-796.
28. Van den Berghe G, Van Roosbroeck D, Vanhove P, Wouters PJ, De Pourcq L, and Bouillon R: Bone turnover in prolonged critical illness: Effect of vitamin D. J Clin Endocrinol Metab 2003;88:4623-4632.
29. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, and Koerfer R: Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: A double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006;83:754-759.